石四药集团维生素 A 棕榈酸酯获批准登记成为在上市制剂使用的原料药

Core Viewpoint - The company Shijiazhuang Pharmaceutical Group (stock code: 02005) has received approval from the National Medical Products Administration of China for its Vitamin A Palmitate to be registered as an active pharmaceutical ingredient for use in marketed formulations [1] Group 1 - The approved Vitamin A Palmitate is primarily used in lipid-soluble vitamin injections to supplement vitamins [1]